Legend Capital-Backed Harbour BioMed Acquires US Biotech Firm Harbour Antibodies

Shanghai-based biotechnology company Harbour BioMed, backed by Chinese investment firms Advantech Capital and Legend Capital, has acquired Netherlands-headquartered firm Harbour Antibodies BV to create a global oncology-focused biotechnology company.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!


Already have an account or paid subscription? Log in

LEAVE A REPLY